1. Home
  2. HAFN vs RARE Comparison

HAFN vs RARE Comparison

Compare HAFN & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAFN
  • RARE
  • Stock Information
  • Founded
  • HAFN 2012
  • RARE 2010
  • Country
  • HAFN Singapore
  • RARE United States
  • Employees
  • HAFN N/A
  • RARE N/A
  • Industry
  • HAFN
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAFN
  • RARE Health Care
  • Exchange
  • HAFN Nasdaq
  • RARE Nasdaq
  • Market Cap
  • HAFN 2.9B
  • RARE 3.2B
  • IPO Year
  • HAFN N/A
  • RARE 2014
  • Fundamental
  • Price
  • HAFN $6.28
  • RARE $31.85
  • Analyst Decision
  • HAFN Strong Buy
  • RARE Strong Buy
  • Analyst Count
  • HAFN 1
  • RARE 15
  • Target Price
  • HAFN $6.50
  • RARE $87.00
  • AVG Volume (30 Days)
  • HAFN 1.1M
  • RARE 1.4M
  • Earning Date
  • HAFN 11-26-2025
  • RARE 11-04-2025
  • Dividend Yield
  • HAFN 10.06%
  • RARE N/A
  • EPS Growth
  • HAFN N/A
  • RARE N/A
  • EPS
  • HAFN 0.84
  • RARE N/A
  • Revenue
  • HAFN $2,354,657,000.00
  • RARE $630,598,000.00
  • Revenue This Year
  • HAFN N/A
  • RARE $19.65
  • Revenue Next Year
  • HAFN N/A
  • RARE $23.65
  • P/E Ratio
  • HAFN $7.43
  • RARE N/A
  • Revenue Growth
  • HAFN N/A
  • RARE 20.63
  • 52 Week Low
  • HAFN $3.61
  • RARE $25.81
  • 52 Week High
  • HAFN $6.44
  • RARE $53.04
  • Technical
  • Relative Strength Index (RSI)
  • HAFN 56.10
  • RARE 47.59
  • Support Level
  • HAFN $6.08
  • RARE $29.36
  • Resistance Level
  • HAFN $6.27
  • RARE $35.95
  • Average True Range (ATR)
  • HAFN 0.14
  • RARE 1.56
  • MACD
  • HAFN 0.00
  • RARE -0.47
  • Stochastic Oscillator
  • HAFN 72.65
  • RARE 46.13

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: